Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $5.6500 (-4.88%) ($5.6500 - $5.6500) on Tue. Apr. 6, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.08% (three month average) | RSI | 30 | Latest Price | $5.6500(-4.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.2% a day on average for past five trading days. | Weekly Trend | AUTL declines -8.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) BNDX(12%) TLT(11%) BND(9%) XLRE(9%) SKYY(8%) | Factors Impacting AUTL price | AUTL will decline at least -2.04% in a week (0% probabilities). TBT(-11%) UNG(-8%) USO(-6%) XLF(-5%) XLB(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.04% (StdDev 4.08%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-7.84(-238.76%) | Inflection Point | Yes | Resistance Level | $6.24 | 5 Day Moving Average | $5.74(-1.57%) | 10 Day Moving Average | $5.85(-3.42%) | 20 Day Moving Average | $6.24(-9.46%) | To recent high | -39.1% | To recent low | 2.9% | Market Cap | $295m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |